drugset / Trial / NCT04226456
Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the efficacity of N-acetylcystein against Cisplatin-induced ototoxicity.
Timeline
- Start
- 2021-07-10
- Primary completion
- 2023-05-03
- Completion
- 2023-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-acetylcysteine | Small molecule | 0.4 ml | Other |
| Subject | N-acetylcysteine | Small molecule | 1 ml | Other |
| Subject | N-acetylcysteine | Small molecule | 10 % | Other |